Zinc Deficiency Clinical Trial
Official title:
The Efficacy of Zinc-biofortified Rice in Improving Zinc Status in Young Bangladeshi Children, a Double Blind Randomized Controlled Trial
To assess the efficacy of the zinc biofortified rice on plasma zinc concentrations in infants from a rural area of Bangladesh.
Rationale: Around the world and estimated 30% of the population is at risk of Zinc deficiency, mainly due to monotonous plant base diets and the poor bioavailability of this sources. One staple food crop which is low in zinc content is rice. Therefore, zinc deficiency is highly common in Asia. Zinc plays a major role in child growth and neurobehavioral development. Furthermore, it is linked to infection control and normal immune response. One way to add extra zinc to someone's diet is zinc bio fortification of staple crops, which can be a cost saving sustainable approach to improve zinc nutrition. However, data on long-term intake of biofortified crops with zinc is scarce and efficacy of newly developed rice crops high in zinc are not well known. Objective: The objective is to assess the efficacy of a newly developed zinc biofortified rice variety on plasma zinc concentrations in children in a rural area of Bangladesh when compared to their controls in a 9 month randomized controlled trial (RCT). Study design: A double randomized control trial. Study population: Stunted children whom are zinc deficient at start of the study intervention determined by plasma zinc levels <9.9 µmol/L. Main study parameters/endpoints: The difference in zinc status between the intervention and control group expressed in blood plasma zinc levels. Plasma zinc will be measured 4 times during the intervention period. Besides plasma zinc other zinc biomarkers will be tested for their usefulness. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03353662 -
Sub Regional Micronutrient Survey in Ethiopia
|
||
Completed |
NCT02126293 -
Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant
|
Phase 3 | |
Terminated |
NCT01472211 -
Water-based Zinc Intervention Trial in Zinc Deficient Children
|
Phase 0 | |
Completed |
NCT01061307 -
An Efficacy Trial of Iron, Zinc and Vitamin A Fortified Rice in Children in Satun, Thailand
|
Phase 0 | |
Recruiting |
NCT03421314 -
Effect of Zinc and Selenium Supplementation on HIV+ Individuals on Antiretroviral Treatment.
|
N/A | |
Completed |
NCT02292303 -
Clinical Trial to Determine the Bioavailability of Three Different Zinc Preparations
|
N/A | |
Completed |
NCT02241330 -
Efficacy of Zn Biofortified Wheat in Improving Zn Status in Indian School Children With Low Zn Status
|
N/A | |
Completed |
NCT01221129 -
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B)
|
N/A | |
Completed |
NCT04632771 -
Nutritional Status and Bouillon Use in Northern Ghana
|
||
Recruiting |
NCT05236374 -
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
|
N/A | |
Completed |
NCT02758444 -
Effects of EED on Zn Absorption and Retention in Children From a MNP
|
N/A | |
Completed |
NCT02760095 -
Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
|
||
Completed |
NCT02233764 -
Effect of Iron/Zinc-Biofortified Pearl Millet on Growth and Immunity in Children Aged 12-18 Months in India
|
N/A | |
Recruiting |
NCT05527899 -
Zinc Intervention in Elderly for Prevention of Pneumonia
|
Phase 2/Phase 3 | |
Terminated |
NCT04983667 -
Zinc-AA Supplementation During Pregnancy & Lactation to Assess Effects on ASD Prevalence in Offspring
|
N/A | |
Completed |
NCT03293641 -
Zinc Supplementation in Children With Sickle Cell Disease in Western Kenya
|
N/A | |
Completed |
NCT05778383 -
Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes
|
Phase 4 | |
Completed |
NCT04559152 -
Zinc Supplementation During Pregnancy: Analysis of Maternal Serum Zinc, Cord Blood Osteocalcin and Neonatal Birth Length
|
N/A | |
Completed |
NCT01062347 -
A Novel Bio-marker of Zinc Status
|
Phase 1 | |
Recruiting |
NCT05085834 -
Zinc Effect on Inflammation and Cardiovascular Risk in HIV
|
Early Phase 1 |